Autres langues KALA BIO, Inc.

Actions

KALA

US4831192020

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
7,007 ^USD	+3,74%		+11,23%	+0,11%

02/04	KALA BIO, INC. : Opinion positive de HC Wainwright	ZM
29/03	KALA BIO, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01
KALA BIO, Inc. announced that it expects to receive $1.999824 million in funding	21/12
KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	13/11
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	21/09/23
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20/09/23
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	05/09/23
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	07/08/23
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	04/08/23
KALA BIO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K	02/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues KALA BIO, Inc.

Actions

KALA

US4831192020

Autres langues

Filtres